口服硫酸盐溶液与3升聚乙二醇在结肠镜检查前肠道准备中的疗效与安全性比较:一项III期多中心随机对照试验
这项在中国成人中开展的III期多中心随机对照非劣效性试验,将受试者随机分入口服硫酸盐溶液(OSS)组或3升分次聚乙二醇(PEG)组。改良完整分析集(mFAS)中OSS组肠道准备充分率为98.22%,3-L PEG组为97.66%,符合非劣效;两组可接受性及总体不良反应相似。
要点
- mFAS中肠道准备充分率OSS组98.22% vs 3-L PEG组97.66%,达到非劣效。
- 两组可接受性分别为94.74%与94.80%,差异无统计学意义(P = .9798)。
- 总体不良反应发生率OSS组50.88% vs 3-L PEG组44.51%,差异无统计学意义(P = .2370)。
核心结论
- 在中国成人中,分次口服硫酸盐溶液方案的肠道准备质量不劣于分次3升聚乙二醇方案,两组安全性和可接受性相似。
研究设计与样本
- 随机、阳性对照、非劣效性研究,在10个医疗中心开展。
- 受试者随机接受分次口服硫酸盐溶液或分次3升聚乙二醇方案。
- 共入组348例可能合格受试者;完整分析集与安全性集各344例,改良完整分析集340例,符合方案集328例。
- 肠道准备质量采用波士顿肠道准备量表评估,安全性通过不良反应评估。
主要发现
- 改良完整分析集中肠道准备充分率口服硫酸盐溶液组98.22% vs 3升聚乙二醇组97.66%。
- 符合方案集中肠道准备充分率口服硫酸盐溶液组98.17% vs 3升聚乙二醇组98.78%。
- 两组可接受性口服硫酸盐溶液组94.74% vs 3升聚乙二醇组94.80%,差异无统计学意义(P = .9798)。
- 总体不良反应口服硫酸盐溶液组50.88% vs 3升聚乙二醇组44.51%,差异无统计学意义(P = .2370)。
关键数值与推荐
- 改良完整分析集中,口服硫酸盐溶液组肠道准备充分率98.22%不劣于3升聚乙二醇组97.66%。
- 符合方案集中,口服硫酸盐溶液组肠道准备充分率98.17%不劣于3升聚乙二醇组98.78%。
- 可接受性两组分别为94.74%与94.80%(P = .9798)。
- 总体不良反应两组分别为50.88%与44.51%(P = .2370)。
临床怎么用
- 原文结论为分次口服硫酸盐溶液方案的肠道准备质量不劣于分次3升聚乙二醇方案,两组安全性和可接受性相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Adequate bowel preparation is crucial for clear mucosal visualization during colonoscopy. We aimed to comprehensively compare oral sulfate solution (OSS) and 3-L split-dose polyethylene glycol (PEG) for bowel preparation before colonoscopy. METHODS: This randomized, active-controlled, noninferiority study was performed in 10 medical centers. Eligible subjects were enrolled to receive OSS or 3-L PEG in a split-dose regimen. The quality of bowel preparation, adverse reactions, and acceptability were evaluated. The quality of bowel preparation was evaluated using the Boston Bowel Preparation Scale. Safety was evaluated by adverse reactions. The study population was divided into the full analysis set (FAS), the safety set, the modified FAS (mFAS), and the per-protocol set (PPS). RESULTS: Three hundred forty-eight potentially eligible subjects were enrolled. Three hundred forty-four subjects were included in the FAS and safety set, 340 subjects were included in the mFAS, and 328 subjects were included in the PPS. Adequate bowel preparation of the OSS was not inferior to 3-L PEG in the mFAS (98.22% vs 97.66%) and the PPS (98.17% vs 98.78%). There was no significant difference in acceptability between the 2 groups (94.74% vs 94.80%, P = .9798). Overall adverse reactions were similar (50.88% vs 44.51%, P = .2370) between the 2 groups. CONCLUSIONS: The split-dose OSS regimen was not inferior to the split-dose 3-L PEG regimen for the quality of bowel preparation in a Chinese adult population. The safety and acceptability of the 2 groups were similar. (Clinical trial registration number: NCT05465889.).
引用
- Pan P, Zhao S, Wang S, et al. Comparison of the efficacy and safety of an oral sulfate solution and 3-L polyethylene glycol on bowel preparation before colonoscopy: a phase III multicenter randomized controlled trial. Gastrointest Endosc. 2023. PMID: 37422241. doi:10.1016/j.gie.2023.06.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。